Safety Considerations and Side Effects of GLP-1 Treatments Whilst GLP-1 receptor agonists have demonstrated efficacy for weight management, understanding their safety profile is essential for informed decision-making
Solid product and Ill be reordering
The author is not disseminating any information, which the author believes or knows, is confidential or in conflict with the privacy of any person
doi: 10.1177/1759720x18776224 131 SchettGTohidast-AkradMSmolenJSSchmidBJSteinerCWBitzanPet al
Some patients might also experience headaches, lightheadedness, or stomach upset, such as mild nausea [2]
Our focus in 2024 will be on reaching more patients, progressing and expanding our pipeline as well as the continued significant expansion of our production capacity." News Peg The stellar success of Ozempic and Wegovyboth branded drugs containing the same active ingredient, semaglutidehas rapidly propelled Novo Nordisk into a rarified club of extraordinarily valuable companies and triggered an acknowledged period of unusual growth for a company of its size